FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes - FDA.gov

KFGO

FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes FDA.gov The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and ... FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug HumalogReuters FDA Gives Final OK to First Short-Acting Follow-On Insulin for DiabetesPharmacy Times FDA Says 'Yes' to Short-Acting Insulin AdmelogMedPage Today Markets Insider -MD Magazine -AJMC.com Managed Markets Network -StreetInsider.com all 14 news articles »

from Health - Google News http://ift.tt/2BCldvm